Ulcerative Colitis Chronic trials recruiting in New York

Fewer than 3 recruiting trials found.

All Ulcerative Colitis Chronic trials nationally

Cities in New York

Recruiting trials in New York

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · New York: New York
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
  NCT06598943 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Brooklyn, Jackson Heights, New York, Utica